Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroleptic malignant syndrome: recognizing an unrecognized killer.

J F Hooper1, C K Herren, H Goldwasser

  • 1Taylor Harden Secure Medical Facility, Tuscaloosa, Alabama.

Journal of Psychosocial Nursing and Mental Health Services
|July 1, 1989
PubMed
Summary

Nurses and physicians should recognize neuroleptic Malignant Syndrome (NMS) as a serious condition. Early identification of NMS symptoms like fever and movement issues is crucial for patient safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

House calls and alprazolam for agoraphobia.

American family physician·1991
Same author

New and future treatment of depression.

Alabama medicine : journal of the Medical Association of the State of Alabama·1989
Same author

Prediction of neuroleptic-induced dystonia.

Journal of clinical psychopharmacology·1989
Same author

Concomitant treatment of neuroleptic malignant syndrome and psychosis.

The British journal of psychiatry : the journal of mental science·1989
Same author

Neuroleptic malignant syndrome.

American family physician·1988
Same author

Droperidol and acute psychosis.

Journal of clinical psychopharmacology·1987

Area of Science:

  • Neuroscience
  • Clinical Medicine
  • Pharmacology

Background:

  • Neuroleptic Malignant Syndrome (NMS) is a rare but severe adverse reaction to antipsychotic medications.
  • Historically, NMS has been underrecognized and misdiagnosed as other conditions.

Observation:

  • Increased recognition of NMS cases suggests improved diagnostic awareness rather than a true rise in incidence.
  • NMS can present with subtle symptoms, leading to misdiagnosis as pneumonia or urinary tract infections.
  • Sudden deaths associated with neuroleptic use may be attributable to undiagnosed NMS.

Findings:

  • Key indicators for potential NMS include fever, fluctuating vital signs, and motor disturbances (difficulty with movement).
  • Prompt recognition and intervention are critical for managing NMS and preventing severe outcomes.

Related Experiment Videos

Implications:

  • Healthcare professionals, particularly nurses and physicians in psychiatric settings, must maintain a high index of suspicion for NMS.
  • Enhanced awareness and diagnostic capabilities for NMS can improve patient outcomes and reduce mortality.
  • Distinguishing NMS from other conditions is vital for appropriate treatment and patient management.